Philips is recalling its remote cardiac monitoring software, which has been associated with 109 reported injuries and two reported deaths, according to the Food and Drug Administration.

Philips will sell its emergency care business to investment firm Bridgefield Capital for an undisclosed amount. The deal is ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect cases of hidden, transient arrhythmias that may only last minutes | According ...

Philips is recalling the software associated with its mobile cardiac outpatient telemetry devices after 109 patient injuries and two patient deaths, a Jan. 13 FDA recall notice said. The software ...

Philips has signed an agreement for the sale of its Emergency Care business to US-based investment firm Bridgefield Capital.

The deal includes a licensing agreement that allows the sold business to use the Philips brand for up to 15 years.

Philips’ application software for outpatient monitoring is used to analyze, display and report symptomatic and asymptomatic cardiac events in ECG data received from devices. The data is then ...

Philips and Myocardial Solutions have collaborated to bring innovative, AI-driven imaging technologies to the field of cardio-oncology. By enhanc ...

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic today announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic ...

SGMC Health is raising the bar in cardiac care with the introduction of a cutting-edge Cardiac Electrophysiology (EP) Lab at ...

Royal Philips launched the AI-enabled CT 5300 at the 23rd Asian Oceanian Congress of Radiology (AOCR) 2025. The company also ...

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, ...